Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to -$1.1 million.

  • STRATA Skin Sciences' Free Cash Flow fell 19725.27% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.5 million, marking a year-over-year decrease of 7612.84%. This contributed to the annual value of -$1.4 million for FY2024, which is 7385.34% up from last year.
  • As of Q3 2025, STRATA Skin Sciences' Free Cash Flow stood at -$1.1 million, which was down 19725.27% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Free Cash Flow ranged from a high of $246000.0 in Q2 2024 and a low of -$2.6 million during Q1 2023
  • Over the past 5 years, STRATA Skin Sciences' median Free Cash Flow value was -$756000.0 (recorded in 2023), while the average stood at -$921157.9.
  • As far as peak fluctuations go, STRATA Skin Sciences' Free Cash Flow skyrocketed by 15734.87% in 2024, and later plummeted by 86422.76% in 2025.
  • Over the past 5 years, STRATA Skin Sciences' Free Cash Flow (Quarter) stood at -$461000.0 in 2021, then crashed by 229.72% to -$1.5 million in 2022, then soared by 77.17% to -$347000.0 in 2023, then soared by 157.35% to $199000.0 in 2024, then tumbled by 643.72% to -$1.1 million in 2025.
  • Its Free Cash Flow stands at -$1.1 million for Q3 2025, versus -$1.9 million for Q2 2025 and -$749000.0 for Q1 2025.